Results 231 to 240 of about 315,827 (302)

Progression to Dementia in Very Late‐Onset Schizophrenia‐Like Psychosis Stratified by Alzheimer's Disease and Lewy Body Disease Biomarkers: A Retrospective Cohort Study

Psychogeriatrics, Volume 26, Issue 5, September 2026.
ABSTRACT Background Very late‐onset schizophrenia‐like psychosis (VLOSLP) is clinically heterogeneous, and its relationship with dementia‐related neurodegenerative disease remains unresolved. We examined whether Alzheimer's disease (AD) and Lewy body disease (LBD) biomarker status were associated with dementia progression in VLOSLP.
Yuto Satake, Hideki Kanemoto, Daiki Taomoto, Kayo Takeda, Shigeki Katakami, Matasaburo Kobayashi, Keiko Matsunaga, Kayako Isohashi, Takashi Suehiro, Kenji Yoshiyama, Manabu Ikeda   +10 more
wiley   +1 more source

The Pittsburgh Sleep Quality Index and Epworth Sleepiness Scale in frontotemporal dementia and Alzheimer's disease. [PDF]

Alzheimers Dement
Jiang J, Larsen EK, Levett BA, Core LB, Froud SA, Della Monica C, Hassanin H, Atzori G, Hardy CJ, Busche MA, Dijk DJ, Revell VL, Harris SS, Eriksson SH, Warren JD.   +14 more
europepmc   +1 more source

“S‐Tau‐Lled” Lysosomes Disrupt Autophagic Processes in Neurodegeneration

Traffic, Volume 27, Issue 3, September 2026.
Tauopathies are neurodegenerative diseases characterized by misfolded tau accumulation and lysosomal dysfunction. Pathogenic mutant Tau stalls lysosomes in iPSC‐derived neurons upstream of Tau accumulation. Pharmacological activation of autophagy activation reduces Tau burden without rescuing lysosome motility, revealing that trafficking and ...
Anaïs Bécot, Mehdi Kabani
wiley   +1 more source

Inclusion-Body Myopathy with Paget Disease of the Bone and Frontotemporal Dementia (IBMPFD) with <i>SCN4A</i> Mutation: Modifying Factor or Not? [PDF]

Diagnostics (Basel)
Tsujimoto S, Hayashi K, Sato M, Hamada T, Suzuki A, Nakaya Y, Miura T, Nishino I, Yoshioka W, Kobayashi Y.   +9 more
europepmc   +1 more source

Stathmin‐2 mediates paracrine hormone regulation of glucagon through lysosomal trafficking in αTC1‐6 cells

The Journal of Physiology, Volume 604, Issue 17, Page 7225-7245, 1 September 2026.
Abstract figure legend Paracrine regulation of glucagon involves Stathmin2‐mediated trafficking of glucagon through lysosomal transport. Glucagon secretion is regulated by the paracrine hormones insulin and somatostatin. We postulate that insulin enhances lysosomal transport of glucagon away from sites of exocytosis, and somatostatin functions in the ...
Nelson Chang, Samuel Ugulini, Savita Dhanvantari   +2 more
wiley   +1 more source

Affective and cognitive theory of mind and associated brain functional alterations in frontotemporal dementia. [PDF]

Brain Commun
Tripodi C, Canu E, Marangon A, Castelnovo V, Basaia S, Spinelli EG, Cecchetti G, Ghirelli A, Pisano S, Rugarli G, Caso F, Magnani G, Caroppo P, Prioni S, Villa C, Tremolizzo L, Appollonio I, Verde F, Ticozzi N, Silani V, Filippi M, Agosta F.   +21 more
europepmc   +1 more source

Correction: EEG-based classification of alzheimer's disease and frontotemporal dementia using functional connectivity. [PDF]

Sci Rep
Mlinarič T, Van Den Kerchove A, Barinaga ZI, Van Hulle MM.   +3 more
europepmc   +1 more source

Co-morbid seizures in frontotemporal dementia: MRI and PET correlations. [PDF]

Epilepsy Behav Rep
Hashmi SA, Kapur J, Quigg M, D'Abreu A, Manning C, Parikh P, Zawar I.   +6 more
europepmc   +1 more source

Role of Alpha-Synuclein in Frontotemporal Dementia: Narrative Review. [PDF]

Cells
Bougea A.
europepmc   +1 more source

Altered amygdala structural connectivity and relations to social cognition in frontotemporal dementia. [PDF]

Alzheimers Dement
Huang M, Dalton MA, Matis S, Teng HAC, Cheung SC, Hwang YT, Ahmed RM, Landin-Romero R, Piguet O.   +8 more
europepmc   +1 more source